Earnings: Page 10
-
Intuitive forecasts 12%-16% growth in procedures in 2023 even as da Vinci robot sales slowed in Q4
For hospitals that have been reporting growth in robotic procedures, “da Vinci is a relative priority in their capital budgets,” the company said.
By Elise Reuter • Jan. 11, 2023 -
Guardant Health posts revenue growth in Q4 on higher clinical testing volumes
The oncology diagnostics company’s preliminary results beat analyst estimates.
By Nick Paul Taylor • Jan. 10, 2023 -
Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch
Sales are expected to reach $3.35 billion to $3.49 billion for the full year.
By Elise Reuter • Jan. 9, 2023 -
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Teleflex launches another round of restructuring
Rising costs are pushing the device maker to incur restructuring liabilities of $31 million to $40 million.
By Elise Reuter • Nov. 23, 2022 -
Medtronic lowers full-year forecast, citing drop in procedure growth
A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.
By Elise Reuter • Nov. 22, 2022 -
Q3 Earnings Wrap: Bumpy time for medtech with inflation, FX, supply woes
Macroeconomic pressures were a persistent theme for the industry, with workforce reductions a part of the fallout for some companies.
By Susan Kelly • Nov. 21, 2022 -
BD says inflationary pressures persist; COVID-19 test sales plunge
Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata.
By Elise Reuter • Nov. 10, 2022 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring
Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”
By Nick Paul Taylor • Nov. 9, 2022
To find more content, use the "Topics" in the menu above.